Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
Clinical Studies Sweden, Forum South, Skåne University Hospital, Lund, Sweden.
Clin Chem Lab Med. 2018 Feb 23;56(3):422-435. doi: 10.1515/cclm-2017-0563.
Although recommended by the Kidney Disease Improving Global Outcomes, the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPICR) creatinine equation was not targeted to estimate glomerular filtration rate (eGFR) among older adults. The Berlin Initiative Study (BIS1CR) equation was specifically developed in older adults, and the Lund-Malmö revised (LMRCR) and the Full Age Spectrum (FASCR) equations have shown promising results in older adults. Our aim was to validate these four creatinine equations, including addition of cystatin C in a large multicenter cohort of Europeans ≥70 years.
A total of 3226 individuals (2638 with cystatin C) underwent GFR measurement (mGFR; median, 44 mL/min/1.73 m2) using plasma iohexol clearance. Bias, precision (interquartile range [IQR]), accuracy (percent of estimates ±30% of mGFR, P30), eGFR accuracy diagrams and probability diagrams to classify mGFR<45 mL/min/1.73 m2 were compared.
The overall results of BIS1CR/CKD-EPICR/FASCR/LMRCR were as follows: median bias, 1.7/3.6/0.6/-0.7 mL/min/1.73 m2; IQR, 11.6/12.3/11.1/10.5 mL/min/1.73 m2; and P30, 77.5%/76.4%/80.9%/83.5% (significantly higher for LMR, p<0.001). Substandard P30 (<75%) was noted for all equations at mGFR<30 mL/min/1.73 m2, and at body mass index values <20 and ≥35 kg/m2. LMRCR had the most stable performance across mGFR subgroups. Only LMRCR and FASCR had a relatively constant small bias across eGFR levels. Probability diagrams exhibited wide eGFR intervals for all equations where mGFR<45 could not be confidently ruled in or out. Adding cystatin C improved P30 accuracy to 85.7/86.8/85.7/88.7 for BIS2CR+CYS/CKD-EPICR+CYS/FASCR+CYS/MEANLMR+CAPA.
LMRCR and FASCR seem to be attractive alternatives to CKD-EPICR in estimating GFR by creatinine-based equations in older Europeans. Addition of cystatin C leads to important improvement in estimation performance.
尽管肾脏病预后质量倡议(Kidney Disease Improving Global Outcomes,KDIGO)推荐使用慢性肾脏病流行病学合作(Chronic Kidney Disease Epidemiology collaboration,CKD-EPIC)肌酐方程来估算肾小球滤过率(glomerular filtration rate,eGFR),但该方程并非针对老年人设计。柏林倡议研究(Berlin Initiative Study,BIS1CR)方程是专门为老年人开发的,而 Lund-Malmö 修订版(Lund-Malmö revised,LMRCR)和全年龄谱(Full Age Spectrum,FASCR)方程在老年人中显示出了良好的结果。我们的目的是在一个大型的欧洲≥70 岁多中心队列中验证这四个肌酐方程,包括在方程中加入胱抑素 C。
共有 3226 名个体(2638 名个体检测了胱抑素 C)接受了使用血浆碘海醇清除率测量的肾小球滤过率(GFR;中位数为 44 ml/min/1.73 m2)。比较了 BIS1CR/CKD-EPICR/FASCR/LMRCR 这四个方程的偏倚、精度(四分位距 [interquartile range,IQR])、准确性(估计值与 mGFR 的 30%的差异百分比,P30)、eGFR 准确性图和用于分类 mGFR<45 ml/min/1.73 m2 的概率图。
BIS1CR/CKD-EPICR/FASCR/LMRCR 的总体结果如下:中位数偏倚分别为 1.7/3.6/0.6/-0.7 ml/min/1.73 m2;IQR 分别为 11.6/12.3/11.1/10.5 ml/min/1.73 m2;P30 分别为 77.5%/76.4%/80.9%/83.5%(LMR 显著更高,p<0.001)。所有方程在 mGFR<30 ml/min/1.73 m2 时 P30 均低于 75%,在 BMI<20 和≥35 kg/m2 时也如此。LMRCR 在各 GFR 亚组中的性能最稳定。只有 LMRCR 和 FASCR 在整个 eGFR 水平上具有相对稳定的小偏倚。概率图显示,对于所有方程,eGFR 水平的范围较宽,以至于 mGFR<45 不能被有信心地判定为存在或不存在。加入胱抑素 C 可将 BIS2CR+CYS/CKD-EPICR+CYS/FASCR+CYS/MEANLMR+CAPA 的 P30 准确性提高到 85.7/86.8/85.7/88.7。
在估计欧洲老年人的 GFR 时,LMRCR 和 FASCR 似乎是 CKD-EPICR 的有吸引力的替代方案。加入胱抑素 C 可显著提高估算性能。